Kenneth J Valenzano Selected Research

1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indole

12/2005	A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
4/2005	Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth J Valenzano Research Topics

Disease

7	Fabry Disease (Fabry's Disease) 01/2017 - 01/2010
5	Glycogen Storage Disease Type II (Pompe's Disease) 01/2019 - 12/2009
4	Pain (Aches) 02/2006 - 07/2003
3	Gaucher Disease (Gaucher's Disease) 01/2017 - 04/2010
3	Chronic Pain 12/2005 - 07/2003
2	Alzheimer Disease (Alzheimer's Disease) 07/2014 - 04/2012
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2013 - 01/2012
2	Ataxia (Dyssynergia) 12/2005 - 04/2005
2	Catalepsy 12/2005 - 04/2005
2	Hyperalgesia 04/2005 - 07/2003
2	Inflammation (Inflammations) 04/2005 - 08/2004
1	Metabolic Diseases (Metabolic Disease) 07/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2014
1	Muscle Weakness 01/2014
1	Sandhoff Disease (Sandhoff's Disease) 04/2012
1	Disease Progression 01/2012
1	Obesity 12/2010
1	Heart Diseases (Heart Disease) 02/2006
1	Epilepsy (Aura) 02/2006
1	Neuralgia (Stump Neuralgia) 07/2003

Drug/Important Bio-Agent (IBA)

7	AcidsIBA 01/2019 - 12/2009
6	GlucosidasesIBA 01/2019 - 01/2012
6	EnzymesIBA 01/2019 - 04/2010
6	GalactosidasesIBA 01/2017 - 08/2011
4	GlycogenIBA 01/2019 - 01/2012
4	globotriaosylceramide (globotriosylceramide)IBA 07/2015 - 01/2010
3	migalastatIBA 01/2017 - 01/2010
2	human GAA protein (Myozyme)FDA Link 01/2019 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 04/2012
2	HydrolasesIBA 07/2015 - 04/2012
2	alpha-Glucosidases (Acid Maltase)IBA 01/2014 - 12/2009
2	Lysergic Acid Diethylamide (LSD)IBA 04/2012 - 12/2009
2	1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indoleIBA 12/2005 - 04/2005
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2005 - 04/2005
2	Analgesics (Analgesic Drugs)IBA 12/2005 - 07/2003
2	CB2 Cannabinoid ReceptorIBA 12/2005 - 04/2005
2	capsazepineIBA 07/2003 - 07/2003
2	Capsaicin (Zostrix)FDA Link 07/2003 - 07/2003
1	miglustat (Zavesca)FDA Link 01/2019
1	Glucosylceramides (Glucocerebrosides)IBA 01/2017
1	sphingosyl beta-glucosideIBA 01/2017
1	larazotide acetateIBA 07/2015
1	agalsidase alfaIBA 01/2015
1	agalsidase beta FDA Link 01/2015
1	GlycosphingolipidsIBA 07/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Amyloid (Amyloid Fibrils)IBA 04/2012
1	GangliosidesIBA 04/2012
1	G(M2) Ganglioside (Ganglioside GM2)IBA 04/2012
1	LipidsIBA 04/2012
1	Peptides (Polypeptides)IBA 04/2012
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 12/2010
1	isofagomineIBA 04/2010
1	beta-GlucosidaseIBA 04/2010
1	Glucosylceramidase (Glucocerebrosidase)IBA 04/2010
1	alpha-Galactosidase (Beano)IBA 01/2010
1	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 12/2009
1	Voltage-Gated Sodium ChannelsIBA 02/2006
1	CannabinoidsIBA 12/2005
1	Cannabinoid Receptor AgonistsIBA 04/2005
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2004
1	TRPV Cation ChannelsIBA 07/2003
1	CationsIBA 07/2003
1	LigandsIBA 07/2003

Therapy/Procedure

4	Enzyme Replacement Therapy 01/2019 - 01/2012
3	Therapeutics 01/2015 - 12/2010
2	Oral Administration 01/2014 - 01/2010
1	Intravenous Administration 07/2015
1	Analgesia 04/2005